REG - Invesco Markets III - Notice to Shareholders

BNP Paribas SAAnnouncement

13/01/2026 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260113:nRSM7397Oa&default-theme=true

RNS Number : 7397O  Invesco Markets III PLC  13 January 2026

 

 

 

 

 

Invesco Markets III Plc

Ground Floor, 2 Cumberland Place, Fenian Street, Dublin 2, Ireland

_________________________________________

Telephone +353 1 439 8000

www.invesco.com (http://www.invesco.com/)

 

 

 

 

 

 

 

 

IMPORTANT: This document is important and requires your immediate attention.
If you are in any doubt as to the action you should take you should seek
advice from your stockbroker, bank manager, solicitor, accountant or other
independent financial adviser.

If you have sold or transferred all of your shares in the Fund (as defined
below), please pass this document at once to the purchaser or transferee or to
the stockbroker, bank or other agent through whom the sale or transfer was
effected for transmission to the purchaser or transferee as soon as possible.

Capitalised terms used herein shall bear the same meaning as capitalised terms
used in the Prospectus dated 16 June 2025. Copies of the Prospectus are
available upon request during normal business hours from the registered office
of the Company or from the local representative of the Company in each
jurisdiction in which the sub-funds of the Company are registered for public
distribution.

In accordance with the current policy of the Central Bank, this document has
not been reviewed by the Central Bank.

12 January 2026

Invesco Markets III plc (the "Company")

 

 Fund                                     ISIN
 Invesco FTSE RAFI UK 100 UCITS ETF Dist  IE00B23LNN70

(the "Fund")

Dear Shareholder,

 

We are writing to you as a Shareholder in the Fund to inform you that the
board of directors (the "Board") has, with regret, determined that, pursuant
to Clause 10 Appendix II of the Memorandum & Articles of Association of
the Company (the "M&A"), it is in the best interests of the Shareholders
to terminate the Fund with effect from 18 February 2026 (the "Termination
Date").

The decision of the Board to terminate the Fund is based on the advice of the
promoter and investment manager that the continued existence and operation of
the Fund is not economically viable.

Therefore, in accordance with the above provisions of the M&A and the
Prospectus, the Board hereby gives notice of our intention:

i)              cancel the listing of the Fund and the right of
the Fund to be traded on any relevant stock exchanges with effect from close
of business on 16 February 2026;

ii)             terminate the Fund with effect from 18 February
2026; and

iii)            to proceed with the compulsory repurchase of all
outstanding shares of the Fund.

 

 PROPOSED TIMETABLE Key Dates  Event
 16 February 2026 (Monday)     Final Exchange Trading Date
 17 February 2026 (Tuesday)    Final Dealing Date (Voluntary Create/Redeem)
 18 February 2026 (Wednesday)  Mandatory Redemption Trade Date (and Termination Date)
 26 February 2026 (Wednesday)  Redemption Settlement Date

ADDITIONAL INFORMATION

Requests for repurchase or subscription for Shares in the Fund may be made in
the usual manner in accordance with the Prospectus and supplements for the
Fund (the "Supplement") until 17 February 2026.

The following terms and conditions of such compulsory repurchase shall apply
as of the Termination Date:

1. the Fund shall be terminated and the repurchase price for each Class of
Shares of the Fund will be determined by reference to the Net Asset Value of
the respective Class of Shares of the Fund as of the Termination Date. The
costs in relation to the termination will be borne by the Manager;

2. no repurchase charge will be applied;

3. the repurchase proceeds will be paid in the relevant Share Class currency;

4. the payment of the repurchase proceeds resulting from the compulsory
repurchase will take place on or around 26 February 2026; and

5. following the payment of the repurchase proceeds in respect of the Fund,
application will be made to the Central Bank of Ireland for the withdrawal of
approval of the Fund.

Shareholders who subscribe or repurchase Shares in the Fund on the primary
market are entitled to repurchase their Shares in the Fund in accordance with
the Prospectus. Please note that the Company does not charge any repurchase
fee for the sale of Shares in the secondary market. Orders to sell Shares
through a stock exchange can be placed via an authorised intermediary or
stockbroker. However, Shareholders should note that orders in the secondary
market may incur costs over which the Company has no control and to which the
above disapplication of the repurchase charge does not apply.

Shareholders may obtain the Prospectus, a copy of the Supplements, the key
investor information and key information documents, the latest annual and
semi-annual reports and copies of the M&A free of charge from the
registered office of the Manager or the local representatives in the countries
where the Company is registered and in Switzerland at BNP Paribas Securities
Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002 Zurich which is
the Swiss representative and paying agent, as well as from the German
information agent Marcard, Stein & Co AG, Ballindamm 36, 20095 Hamburg,
Germany and where applicable on the website of the Company -
www.etf.invesco.com. (http://www.etf.invesco.com/) Shareholders should consult
their own professional advisers as to the specific tax implications of the
termination under the laws of the countries of their nationality, residence,
domicile or incorporation.

If you have any queries arising from this notice, please call Invesco on +353
1 439 8000 or contact us at invest@invesco.com. (mailto:invest@invesco.com)

Yours sincerely

 _____________________

Deirdre Gormley Director

For and on behalf of Invesco Markets III plc

 

 

 

 

Invesco Markets III plc is regulated by the Central Bank of Ireland An
umbrella investment company with variable capital

and having segregated liability between its sub-funds Directors: Gary Buxton
(British/Irish), Deirdre Gormley, Sarah (Katy Walton) Jones (British), Lisa
Martensson (Swedish)

 

Incorporated in Ireland No 352941

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUORORNBUAAAR



            Copyright 2019 Regulatory News Service, all rights reserved